Kim Ji-Yeon, Joung Kyoung-Woon, Kim Kyung-Mi, Kim Min-Ju, Kim Joon-Bum, Jung Sung-Ho, Lee Eun-Ho, Choi In-Cheol
Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Pungnap 2-dong, Songpa-gu, Seoul, 138-736, Korea.
Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Crit Care. 2015 Sep 28;19:350. doi: 10.1186/s13054-015-1065-8.
Saline-based and hydroxyethyl starch solutions are associated with increased risk of renal dysfunction. In the present study, we tested the hypothesis that balanced solutions and a limited volume of hydroxyethyl starch solution (renal protective fluid management [RPF] strategy) would decrease the incidence of postoperative acute kidney injury (AKI) and improve clinical outcomes in patients undergoing off-pump coronary artery bypass graft surgery (OPCAB).
We investigated 783 patients who underwent elective OPCAB. All patients who underwent OPCAB between 1 January 2010 and 4 July 2012 formed the control group and were given intravenous fluids with saline-based solutions and unlimited volumes of colloid solutions. All patients who underwent OPCAB between 5 July 2012 and 31 December 2013 formed the RPF group and were given intravenous fluids with RPF. The primary outcome was the incidence of postoperative AKI. Secondary outcomes included the incidence of severe AKI, requirement for renal replacement therapy, renal outcome at the time of discharge, and other clinical outcomes.
Postoperative AKI occurred in 33 patients (14.4 %) in the RPF group compared with 210 patients (37.9 %) in the control group (P < 0.001). The incidences of severe AKI and persistent AKI after OPCAB were significantly lower, and the postoperative extubation time and duration of hospital stay were significantly shorter, in patients in the RPF group than in those in the control group. After adjustment by multivariate regression analyses and inverse probability of treatment weighting adjustment, the RPF group was independently associated with a lower incidence of postoperative AKI, severe AKI, and persistent AKI and a shorter postoperative extubation time and duration of hospital stay.
The RPF strategy is associated with a significantly decreased incidence of postoperative, severe, and persistent AKI in patients undergoing OPCAB, although residual confounding may be present.
基于生理盐水和羟乙基淀粉的溶液与肾功能不全风险增加有关。在本研究中,我们检验了以下假设:平衡溶液和有限体积的羟乙基淀粉溶液(肾脏保护液体管理[RPF]策略)将降低非体外循环冠状动脉搭桥手术(OPCAB)患者术后急性肾损伤(AKI)的发生率并改善临床结局。
我们调查了783例行择期OPCAB的患者。2010年1月1日至2012年7月4日期间所有行OPCAB的患者组成对照组,给予基于生理盐水的溶液和不限量的胶体溶液进行静脉输液。2012年7月5日至2013年12月31日期间所有行OPCAB的患者组成RPF组,给予RPF进行静脉输液。主要结局是术后AKI的发生率。次要结局包括严重AKI的发生率、肾脏替代治疗的需求、出院时的肾脏结局以及其他临床结局。
RPF组有33例患者(14.4%)发生术后AKI,而对照组有210例患者(37.9%)发生术后AKI(P<0.001)。RPF组患者OPCAB术后严重AKI和持续性AKI的发生率显著更低,术后拔管时间和住院时间显著更短。经多变量回归分析和治疗权重逆概率调整后,RPF组与术后AKI、严重AKI和持续性AKI的发生率更低以及术后拔管时间和住院时间更短独立相关。
RPF策略与OPCAB患者术后、严重和持续性AKI的发生率显著降低相关,尽管可能存在残余混杂因素。